Under the leadership of Mani Daneshmand, MD, Emory has been making transformational changes to its heart and lung failure and transplant programs. They have been brought together into one comprehensive program to improve care and coordination for patients and their families, along with providing the highest quality of care.
The goal — create a future where no Georgia resident will need to leave the state to get advanced heart and lung failure care.
Dr. Daneshmand joined Emory in June after leaving Duke University Medical Center where he served as surgical director of lung and heart-lung transplantation and surgical director of the Extracorporeal Life Support Program. He has been eager to apply his experiences and insights here at Emory.
When asked what his vision is for the programs, Dr. Daneshmand says, “I see a bright future for Emory Healthcare and for the heart transplant, lung transplant and mechanical circulatory support programs at Emory. We are working towards becoming a national leader in high quality, high volume clinical care, but we also want to be a national leader in innovation and development.”
Dr. Daneshmand’s goal is to continue to improve access to care, the quality of care, and the technologies that deliver care. These changes allow Emory to deliver the high-quality care patients in Georgia and across the Southeast need.
“Emory Transplant Center is excited to have Dr. Daneshmand, and we look forward to continuing to work very closely with him to provide excellent and innovative care to patients with heart and lung disease,” says Thomas Pearson, MD, DPhil, executive director of the Emory Transplant Center and Livingston Professor of Surgery in the Division of Transplantation, Department of Surgery at Emory.
“We are excited for Dr. Daneshmand’s future here at Emory as a leading innovator and expert in the field, as we expand our services for patients with heart and lung disease in Georgia and the Southeast,” says Michael E. Halkos, MD, MSc, chief of the Division of Cardiothoracic Surgery and professor of surgery in the Department of Surgery, Emory University School of Medicine. “While at Duke, Dr. Daneshmand helped develop its program into one of the leading thoracic transplant and mechanical circulatory support programs in the U.S. Our goal is for Emory to be one of the top five heart and lung transplant and mechanical circulatory support programs in the country within the next five years.”
or call 404-778-7777.
Mani Daneshmand, MD, joined Emory from Duke University Medical Center, where he served as surgical director of lung and heart-lung transplantation and surgical director of the Extracorporeal Life Support Program.
His research interests focus on the causes of and treatments for advanced heart and lung failure to identify new therapies. With Daneshmand’s arrival, Emory’s heart and lung transplant, mechanical circulatory and ECMO programs will consolidate services into one comprehensive program, improving care coordination for patients and their families, and providing world-class transplant and life support services to the people of Georgia and the entire Southeast.
Emory Transplant Center
Emory Transplant Center offers a comprehensive organ-transplantation program, providing clinical excellence and new transplant therapies for patients in need of heart, lung, kidney, liver and pancreas transplants. Based on Organ Procurement and Transplantation Network 2019 data, Emory Transplant Center ranks among the top 16 transplant programs in the nation for overall adult volume, performing more than 9,900 transplants to date.
For more information about the Emory Transplant Center or to schedule an appointment at any one of our satellite locations, call 855-EMORY-TX (366-7989) or visit emoryhealthcare.org/transplant.